D-0129-2017 Class III Terminated
FDA drug recall D-0129-2017 was initiated by Wells Pharmacy Network, LLC on Sep 19, 2016 and is designated Class III. Reason for recall: Superpotent and Subpotent drugs The recall status is terminated (terminated Mar 29, 2017). Affected quantity: 322 pellets.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 16, 2016
- Initiation Date
- Sep 19, 2016
- Termination Date
- Mar 29, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 322 pellets
Product description
Testosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy Network
Reason for recall
Superpotent and Subpotent drugs
Distribution pattern
U.S.
Code information
Lot Number 08052016@3, BUD 02/01/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0129-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026